Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04813510Not ApplicableUnknown

Effect of Electroacupuncture on SAP With MODS

Role: lead

NCT05053763Not ApplicableUnknown

The 90% Effective Dose of Remimazolam for Duodenoscopy Insertion During ERCP With Alfentanil 10µg/kg

Role: lead

NCT04646629Not ApplicableUnknown

Effect of Electroacupuncture on Sepsis-induced Intestinal Dysfunction

Role: lead

NCT04647201Unknown

Study of Biomarkers in Patients of Sepsis Complicated With Gastrointestinal Dysfunction

Role: lead

All 4 trials loaded